Search details
1.
High-Sensitivity Cardiac Troponin Assays: Ready for Prime Time!
Annu Rev Med
; 75: 459-474, 2024 Jan 29.
Article
in English
| MEDLINE | ID: mdl-37722708
2.
In higher-risk, statin-intolerant adults with diabetes, bempedoic acid reduced MACE at a median 3 y.
Ann Intern Med
; 177(4): JC39, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38560908
3.
In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
Ann Intern Med
; 177(3): JC26, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38437696
4.
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Circulation
; 148(9): e9-e119, 2023 08 29.
Article
in English
| MEDLINE | ID: mdl-37471501
5.
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
Respir Res
; 25(1): 58, 2024 Jan 25.
Article
in English
| MEDLINE | ID: mdl-38273290
6.
In HF with iron deficiency, IV ferric derisomaltose was associated with lower rates of HF hospitalization or CV death.
Ann Intern Med
; 176(4): JC40, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37011388
7.
In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 mo.
Ann Intern Med
; 176(7): JC75, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37399554
8.
In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.
Ann Intern Med
; 176(11): JC123, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37931259
9.
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
Am Heart J
; 266: 61-73, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37604357
10.
Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).
Ann Intern Med
; 175(5): JC58, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35500266
11.
Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C.
Ann Intern Med
; 175(8): JC86, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35914252
12.
In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality.
Ann Intern Med
; 175(3): JC26, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35226528
13.
In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y.
Ann Intern Med
; 175(11): JC126, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36315955
14.
Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association.
Circulation
; 144(19): e287-e305, 2021 11 09.
Article
in English
| MEDLINE | ID: mdl-34601955
15.
Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association.
Circulation
; 143(7): e239-e248, 2021 02 16.
Article
in English
| MEDLINE | ID: mdl-32954796
16.
Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm.
Circulation
; 144(10): 773-787, 2021 09 07.
Article
in English
| MEDLINE | ID: mdl-34376064
17.
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?
Curr Atheroscler Rep
; 24(8): 627-634, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35653033
18.
In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
Ann Intern Med
; 174(3): JC27, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33646845
19.
In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.
Ann Intern Med
; 172(12): JC65, 2020 06 16.
Article
in English
| MEDLINE | ID: mdl-32539517
20.
In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.
Ann Intern Med
; 173(12): JC71, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-33316194